Speaker Profile
PhD, Head of Supply Chain & CMC Portfolio, Sana Biotechnology
Biography
Laura Deschenes has broad experience in the development of novel medicines from preclinical to late stage development. Her current focus is establishing a scalable and sustainable end to end supply chain that delivers Sanas transformative cell and gene therapy treatments to patients, which entails navigating the complexities of time and temperature sensitive materials, customized components, evolving global regulations, and a fluid landscaping of manufacturing options as well as the core supply chain capabilities of supply and demand planning, packaging and labeling, and shipping and logistics. In previous roles, she has established supply chain and operations for a portfolio of autologous and allogeneic cell therapies, and led the clinical supply chain for a portfolio of biologics and small molecules, as well as various strategic roles in business operations, program, and project leadership.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Sharon Benzeno, Adaptive Biotechnologies
- PMWC 2024 Award Ceremony
Pioneer Honoree: Stanley Riddell, Fred Hutchinson
Pioneer Honoree: George Coukos, Ludwig Cancer Center
- Keynote: Engineering Synthetic T Cell States for Cancer Rejection
- George Coukos, Ludwig Cancer Center
- Discovery of Novel Targets in Cell Therapies in Oncology and Autoimmune Disorders (PANEL)
Chair: Harlan Robins, Adaptive Bio
- Stanley Riddell, Fred Hutchinson
- Allison Betof Warner, Stanford
- Lawrence Fong, UCSF - Supply Chain 2.0 Getting Cell Therapies to Patients (PANEL)
Chair: Jean Xu, Janssen Pharmaceuticals
- Amanda Pace, Sonoma Bio
- Laura Deschenes, Sana Biotechnology - Evolving Case Law and Practical Strategies for Immunotherapy Patents
- Janet Xiao, Morrison & Foerster LLP
- Emerging Clinical Data in Oncology Cell Therapeutics
Chair: Andrew Allen, Gritstone bio, Inc.
- Robert Meehan, Moderna - Scientific Advancements in Individualized Cell Therapies in Oncology ( PANEL)
Chair: Sharon Benzeno, Adaptive Biotechnologies
- Ira Mellman, Genenetch
- Robert Meehan, Moderna
- Dirk Nagorsen, Affini-T Therapeutics - AI-Enhanced Approaches in Cell Therapy Development
Chair: Suchit Jhunjhunwala, Genentech
- Brian Weitzner, Outpace Bio
- PMWC Showcase
- Arun Wiita, UCSF
